---
title: "REFINE PHARMA LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/58eee08a-876a-5dd9-a56a-dd7c2e720fc3
json: https://whiteintel.dev/api/public/dossier/58eee08a-876a-5dd9-a56a-dd7c2e720fc3
identifier: oo:GB-COH-13729940
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# REFINE PHARMA LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-13729940`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/58eee08a-876a-5dd9-a56a-dd7c2e720fc3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/58eee08a-876a-5dd9-a56a-dd7c2e720fc3  

## Ownership & control

### Owners / controllers

- **Mr Bradley Tyson** (beneficial owner) — 50% — https://whiteintel.dev/entity/4833d8c3-e505-59a2-b19b-754fdb8f0e4f
- **Mr Jarnail Singh Kang** (beneficial owner) — 50% — https://whiteintel.dev/entity/eabbc2ee-261c-5de4-8753-092ae001c776
- **REFINE GROUP HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/9df7d9e1-cdb5-5224-a65f-4efec1529ece
- **Mr Bradley Tyson** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/8e86f1b2-b09b-4270-abea-37c96eb75f6c
- **Mr Jarnail Singh Kang** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/0abcedcf-722b-4224-9990-4a0d5494f1af

### Holdings / subsidiaries

- **LMBJ LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/8e15ecb6-8fd1-5596-b7a8-517a1770a77a
- **KBAL LTD** (beneficial owner) — 50% — https://whiteintel.dev/entity/a501c6c4-664e-5365-adec-1b9acb759746
- **KBAL LTD** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/a501c6c4-664e-5365-adec-1b9acb759746
- **LMBJ LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/8e15ecb6-8fd1-5596-b7a8-517a1770a77a

### UBO chain (walk to the ultimate owner)

A **7-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `13729940`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2021-11-08
- **Registered office:** 80 St. Georges Road, Bolton, BL1 2DD, England
- **SIC:** 21200

### Officers

- TYSON, Bradley Steven — director · British · appointed 2023-03-15
- [REFINE GROUP HOLDINGS LIMITED](https://whiteintel.dev/entity/9df7d9e1-cdb5-5224-a65f-4efec1529ece) — corporate director · appointed 2023-02-02
- KANG, Jarnail Singh — director · British · appointed 2021-11-08 · resigned 2025-07-01
- TYSON, Bradley Steven — director · British · appointed 2021-11-08 · resigned 2023-01-02

### Beneficial owners (Persons with Significant Control)

- [Refine Group Holdings Limited](https://whiteintel.dev/entity/9df7d9e1-cdb5-5224-a65f-4efec1529ece) — 75–100% shares · corporate PSC · England — since 2026-01-22
- Mr Bradley Tyson — 75–100% shares · individual PSC · England — ceased 2026-01-22
- Mr Jarnail Singh Kang — 25–50% shares · individual PSC · England — ceased 2025-12-02

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/13729940
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/13729940

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **REFINE PHARMA LTD**. Human view: https://whiteintel.dev/entity/58eee08a-876a-5dd9-a56a-dd7c2e720fc3 · Structured JSON: https://whiteintel.dev/api/public/dossier/58eee08a-876a-5dd9-a56a-dd7c2e720fc3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._